EN
HI
Summary
As of 5 Nov, 2026, Evonile Pharma stock price is ₹1714.3. During the trading session, the stock has moved between an intraday low of ₹1600.10 and an intraday high of ₹1738.00. Over the last 52 weeks, Evonile Pharma has traded between ₹950.00 and ₹2588.80.
The stock has recorded a trading volume of 77,675 shares,. Its Average Traded Price (ATP) is ₹1677.38, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 20 @ ₹1714.30.
Evonile Pharma has an upper circuit limit of ₹2066.80 and a lower circuit limit of ₹1378.00. The total value traded stands at ₹13.03 CR, and the delivery percentage for the day is 67.62%.
The stock is currently traded with a market lot size of 1. Evonile Pharma also offers a dividend yield of 0%.
Evonile Pharma Share Price Chart
Evonile Pharma Share Key Metrics
Volume
77675.00
Market Cap
4232.74 CR
LTQ@LTP
20@1714.30
ATP
1677.38
Var Margin
24.34 %
Circuit Range
1378-2066.8
Delivery %
67.62 %
Value
13.03 CR
ASM/GSM
No
Market Lot
1
Evonile Pharma Resistance and Support
Pivot 1713
Resistance
First Resistance
1753.5
Second Resistance
1784.6
Third Resistance
1825.1
Support
First Support
1681.9
Second Support
1641.4
Third Support
1610.3
Evonile Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Wed Nov 04 2026 | 1650 | 1714.3 | -0.47% | 1738 | 1600.1 |
| Tue Nov 03 2026 | 1739 | 1722.4 | 0.27% | 1744.09 | 1672.5 |
| Mon Nov 02 2026 | 1709 | 1717.69 | 1.49% | 1799.59 | 1693.3 |
Evonile Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-11-04 | Rights issue of Equity Shares |
| 2026-10-08 | Rights issue of Equity Shares |
| 2026-07-23 | Quarterly Results |
| 2025-10-28 | Quarterly Results |
| 2026-11-03 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-01-28 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-09 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
| 2024-10-25 | Quarterly Results |
Evonile Pharma News
Evonile Pharma Ltd - 500672 - Intimation Of The Record Date Fixed For The Rights Issue Of The Partly Paid-Up Equity Shares Of The Company.
Evonile Pharma has announced November 11, 2026, as the record date for its upcoming rights issue of ₹8,847.54 million. The issue offers shares at ₹860 each in a 5:12 entitlement ratio, opening on November 19, 2026.
Nov 04 2026 19:46:34
Evonile Pharma Ltd - 500672 - Board Meeting Outcome for Outcome Of The Board Meeting Held Today I.E. November 04, 2026
Evonile Pharma board approved a rights issue to raise up to ₹900 crores via partly paid-up equity shares. The board also approved the payment schedule, utilization of proceeds, and the Letter of Offer to be filed with BSE and SEBI.
Nov 04 2026 19:15:45
Read More
Evonile Pharma Management
| Name | Position |
|---|---|
| Chandni Maru | Company Secretary & Compliance Officer |
| Christopher Snook | Chairperson |
Evonile Pharma Similar Stocks
Mayur Uniquoters Ltd.
787.75
34.20 (4.54%)
Refex Industries Ltd.
222.36
4.40 (2.02%)
Navneet Education Ltd.
132.88
2.16 (1.65%)
BLS E-Services Ltd.
148.44
1.14 (0.77%)
Prabha Energy Ltd
195.22
9.82 (5.30%)
D.B. Corp Ltd.
154.88
6.99 (4.73%)
EFC (I) Ltd.
164.95
-0.70 (0.42%)
Flair Writing Industries Ltd.
239.13
3.61 (1.53%)
Shanti Educational Initiatives Ltd.
161.48
6.42 (4.14%)
Evonile Pharma FAQs
The Buying Price of Evonile Pharma share is 1714.3 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Evonile Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Evonile Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Evonile Pharma shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Evonile Pharma shares is 0. Useful to assess the stock's value relative to its book value.
To assess Evonile Pharma’s valuation compare Sector P/E, P/B which are 59.9 & 1.75 with sector averages, along with growth rates and financial metrics.
The Market Cap of Evonile Pharma is 4232.74 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Evonile Pharma share price is 2588.80 & 950.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Evonile Pharma belongs to the Miscellaneous sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in EVONILE
